Skip to main content

Advertisement

SpringerLink
Log in

C-reactive protein concentration is associated with prognosis in patients suffering from peritoneal carcinomatosis of colorectal origin

  • Original Article
  • Published:
International Journal of Colorectal Disease Aims and scope Submit manuscript

Abstract

Purpose

Only a limited number of patients with peritoneal carcinomatosis (PC) of colorectal origin benefit from palliative chemotherapy. Identification of prognostic factors may aid in patient selection. The plasma concentration of C-reactive protein (CRP) is increasingly recognized as prognostic factor in a variety of malignancies. However, its value in peritoneal PC of colorectal origin is currently unknown. The aim of the present study was to investigate the association of plasma CRP concentrations with survival in patients suffering from PC of colorectal origin who receive palliative chemotherapy.

Methods

Fifty patients with colorectal PC were identified from the Eindhoven Cancer Registry. Relevant data were retrieved from their clinical records. The most discriminatory CRP concentration was identified and patients were stratified accordingly, resulting in a group with low and a group with high CRP concentrations. Further comparisons were made between these groups.

Results

A CRP concentration <35 mg/L was associated with a better prognosis (median survival 22.4 months) than a CRP concentration ≥35 mg/L (7.9 months) (p = 0.0002). CRP concentrations were inversely related to albumin concentrations which could predict survival at a cut-off value of 35 g/L (median survival 7.2 vs. 12.9 months, p = 0.01). High CRP concentrations were related to a decreased resectability rate of the primary tumor.

Conclusion

Elevated CRP plasma concentrations are associated with decreased survival in patients with colorectal PC. This reflects the importance of inflammation in cancer survival. Further research is warranted to assess the clinical applicability of the current findings.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Chu DZ, Lang NP, Thompson C, Osteen PK, Westbrook KC (1989) Peritoneal carcinomatosis in nongynecologic malignancy. A prospective study of prognostic factors. Cancer 63:364–367

    Article  PubMed  CAS  Google Scholar 

  2. Verwaal VJ, Bruin S, Boot H, van Slooten G, van Tinteren H (2008) 8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer. Ann Surg Oncol 15:2426–2432

    Article  PubMed  Google Scholar 

  3. Koppe MJ, Boerman OC, Oyen WJ, Bleichrodt RP (2006) Peritoneal carcinomatosis of colorectal origin: incidence and current treatment strategies. Ann Surg 243:212–222

    Article  PubMed  Google Scholar 

  4. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A (2010) AJCC cancer staging manual. Springer, New York

    Google Scholar 

  5. Ueno H, Mochizuki H, Hashiguchi Y, Ishiguro M, Kajiwara Y, Sato T, Shimazaki H, Hase K, Talbot IC (2008) Histological grading of colorectal cancer: a simple and objective method. Ann Surg 247:811–818

    Article  PubMed  Google Scholar 

  6. Takagawa R, Fujii S, Ohta M, Nagano Y, Kunisaki C, Yamagishi S, Osada S, Ichikawa Y, Shimada H (2008) Preoperative serum carcinoembryonic antigen level as a predictive factor of recurrence after curative resection of colorectal cancer. Ann Surg Oncol 15:3433–3439

    Article  PubMed  Google Scholar 

  7. Ishizuka M, Nagata H, Takagi K, Kubota K (2009) Influence of inflammation-based prognostic score on mortality of patients undergoing chemotherapy for far advanced or recurrent unresectable colorectal cancer. Ann Surg 250:268–272

    Article  PubMed  Google Scholar 

  8. Zacharakis M, Xynos ID, Lazaris A, Smaro T, Kosmas C, Dokou A, Felekouras E, Antoniou E, Polyzos A, Sarantonis J, Syrios J, Zografos G et al (2010) Predictors of survival in stage IV metastatic colorectal cancer. Anticancer Res 30:653–660

    PubMed  CAS  Google Scholar 

  9. Koike Y, Miki C, Okugawa Y, Yokoe T, Toiyama Y, Tanaka K, Inoue Y, Kusunoki M (2008) Preoperative C-reactive protein as a prognostic and therapeutic marker for colorectal cancer. J Surg Oncol 98:540–544

    Article  PubMed  CAS  Google Scholar 

  10. Nozoe T, Mori E, Takahashi I, Ezaki T (2008) Preoperative elevation of serum C-reactive protein as an independent prognostic indicator of colorectal carcinoma. Surg Today 38:597–602

    Article  PubMed  CAS  Google Scholar 

  11. Crozier JE, McKee RF, McArdle CS, Angerson WJ, Anderson JH, Horgan PG, McMillan DC (2007) Preoperative but not postoperative systemic inflammatory response correlates with survival in colorectal cancer. Br J Surg 94:1028–1032

    Article  PubMed  CAS  Google Scholar 

  12. Shiu YC, Lin JK, Huang CJ, Jiang JK, Wang LW, Huang HC, Yang SH (2008) Is C-reactive protein a prognostic factor of colorectal cancer? Dis Colon Rectum 51:443–449

    Article  PubMed  Google Scholar 

  13. Forrest LM, McMillan DC, McArdle CS, Angerson WJ, Dunlop DJ (2003) Evaluation of cumulative prognostic scores based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer. Br J Cancer 89:1028–1030

    Article  PubMed  CAS  Google Scholar 

  14. Gagnon B, Abrahamowicz M, Xiao Y, Beauchamp ME, MacDonald N, Kasymjanova G, Kreisman H, Small D (2010) Flexible modeling improves assessment of prognostic value of C-reactive protein in advanced non-small cell lung cancer. Br J Canc 102:1113–1122

    Article  CAS  Google Scholar 

  15. Pine JK, Fusai KG, Young R, Sharma D, Davidson BR, Menon KV, Rahman SH (2009) Serum C-reactive protein concentration and the prognosis of ductal adenocarcinoma of the head of pancreas. Eur J Surg Oncol 35:605–610

    PubMed  CAS  Google Scholar 

  16. Khandavilli SD, Ceallaigh PO, Lloyd CJ, Whitaker R (2009) Serum C-reactive protein as a prognostic indicator in patients with oral squamous cell carcinoma. Oral Oncol 45:912–914

    Article  PubMed  CAS  Google Scholar 

  17. Pierce BL, Ballard-Barbash R, Bernstein L, Baumgartner RN, Neuhouser ML, Wener MH, Baumgartner KB, Gilliland FD, Sorensen BE, McTiernan A, Ulrich CM (2009) Elevated biomarkers of inflammation are associated with reduced survival among breast cancer patients. J Clin Oncol 27:3437–3444

    Article  PubMed  CAS  Google Scholar 

  18. Vainas T, Stassen FR, de Graaf R, Twiss EL, Herngreen SB, Welten RJ, van den Akker LH, van Dieijen-Visser MP, Bruggeman CA, Kitslaar PJ (2005) C-reactive protein in peripheral arterial disease: relation to severity of the disease and to future cardiovascular events. J Vasc Surg 42:243–251

    Article  PubMed  Google Scholar 

  19. van Dielen FM, Buurman WA, Hadfoune M, Nijhuis J, Greve JW (2004) Macrophage inhibitory factor, plasminogen activator inhibitor-1, other acute phase proteins, and inflammatory mediators normalize as a result of weight loss in morbidly obese subjects treated with gastric restrictive surgery. J Clin Endocrinol Metab 89:4062–4068

    Article  PubMed  Google Scholar 

  20. Moore MM, Chua W, Charles KA, Clarke SJ (2010) Inflammation and cancer: causes and consequences. Clin Pharmacol Ther 87:504–508

    Article  PubMed  CAS  Google Scholar 

  21. Moses AG, Maingay J, Sangster K, Fearon KC, Ross JA (2009) Pro-inflammatory cytokine release by peripheral blood mononuclear cells from patients with advanced pancreatic cancer: relationship to acute phase response and survival. Oncol Rep 21:1091–1095

    PubMed  CAS  Google Scholar 

  22. Wigmore SJ, Redhead DN, Yan XJ, Casey J, Madhavan K, Dejong CH, Currie EJ, Garden OJ (2001) Virtual hepatic resection using three-dimensional reconstruction of helical computed tomography angioportograms. Ann Surg 233:221–226

    Article  PubMed  CAS  Google Scholar 

  23. van de Poll MC, Wigmore SJ, Redhead DN, Beets-Tan RG, Garden OJ, Greve JW, Soeters PB, Deutz NE, Fearon KC, Dejong CH (2007) Effect of major liver resection on hepatic ureagenesis in humans. Am J Physiol 293:G956–G962

    Article  Google Scholar 

  24. Koukourakis MI, Kambouromiti G, Pitsiava D, Tsousou P, Tsiarkatsi M, Kartalis G (2009) Serum C-reactive protein (CRP) levels in cancer patients are linked with tumor burden and are reduced by anti-hypertensive medication. Inflammation 32:169–175

    Article  PubMed  CAS  Google Scholar 

  25. Crozier JE, McMillan DC, McArdle CS, Angerson WJ, Anderson JH, Horgan PG, McKee RF (2007) Tumor size is associated with the systemic inflammatory response but not survival in patients with primary operable colorectal cancer. J Gastroenterol Hepatol 22:2288–2291

    Article  PubMed  Google Scholar 

  26. Damjanov N, Weiss J, Haller DG (2009) Resection of the primary colorectal cancer is not necessary in nonobstructed patients with metastatic disease. Oncologist 14:963–969

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Catharina Hospital Eindhoven, Michelangelolaan 2, 5623 EJ, Eindhoven, The Netherlands

    Marcel C. G. van de Poll, Yvonne L. B. Klaver, Bart J. M. Leenders, Simon W. Nienhuijs & Ignace H. J. T. de Hingh

  2. Comprehensive Cancer Centre South (IKZ), Eindhoven, the Netherlands

    Valery E. P. P. Lemmens

Authors
  1. Marcel C. G. van de Poll
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yvonne L. B. Klaver
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Valery E. P. P. Lemmens
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Bart J. M. Leenders
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Simon W. Nienhuijs
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Ignace H. J. T. de Hingh
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ignace H. J. T. de Hingh.

Electronic supplementary material

Below is the link to the electronic supplementary material.

ESM 1

(JPEG 38 kb)

High resolution (TIFF 1107 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

van de Poll, M.C.G., Klaver, Y.L.B., Lemmens, V.E.P.P. et al. C-reactive protein concentration is associated with prognosis in patients suffering from peritoneal carcinomatosis of colorectal origin. Int J Colorectal Dis 26, 1067–1073 (2011). https://doi.org/10.1007/s00384-011-1187-7

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00384-011-1187-7

Keywords

Search

Navigation